Systemic reactions to antibiotics

Immunology and Allergy Clinics of North America

Volumn 21, Issue 4, 2001, Pages 679-697

  Solensky, R ^a   Mendelson, L M ^a  

^a CT Asthma and Allergy Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN E; PENICILLIN G; PENICILLOIC ACID;

ANAPHYLAXIS; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN TEST;

EID: 0035205380     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Drug allergy
2. Risk factors for drug allergy
3. Routine use of penicillin skin testing on an inpatient service
4. Vancomycin anaphylaxis and successful desensitization
5. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever: International Rheumatic Fever Study Group
6. Tests for penicillin allergy in man. II: The immunological cross-reactivity between penicillin and cephalosporins
7. Anaphylactroid reactions to ciprofloxacin
8. Familial drug allergy
9. Allergic reactions to betalactams: Studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin
10. The immunogenicity of cephalosporin derivatives and their cross-reaction with penicillin
11. Disease management of drug hypersensitivity: A practice parameter
12. Allergy to penicillin with good tolerance to other penicillins: Study of the incidence in subjects allergic to betalactams
13. Fatalities due to anaphylactic reactions to foods
14. Emerging antibiotic resistance
15. Intravenous desensitization to β-lactam antibiotics
16. Drug-induced anaphylaxis: A cooperative study
17. Skin testing and in vitro testing to detect IgE to antimicrobial drugs
18. Long-term ticarcillin desensitization by the continuous oral administration of penicillin
19. Detection, characterization, and desensitization of IgE to streptomycin
20. Penicillin allergy: Anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin
21. Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels
22. Cutaneous disease and drug reactions in HIV infection
23. Anaphylactoid reactions reported after treatment with ciprofloxacin
24. Hypersensitivity and anaphylactoid reactions to ciprofloxacin
25. Drug allergy
26. Acute desensitization of a patient with cystic fibrosis allergic to both β-lactam and aminoglycoside antibiotics
27. Determination of nonirritating concentrations of commonly used antimicrobial drugs
28. Antibody production in normal children receiving penicillin at birth
29. Clinical experience with penicillin skin testing in a large inner-city STD Clinic
30. Ciprofloxacin desensitization
31. Drug allergy
32. Report of the penicillin study group: American Academy of Allergy
33. Evaluation of penicillin hypersensitivity: Value of clinical history and skin testing with penicilloyl-polylysine and penicillin G
34. Recommendations for preventing the spread of vancomycin resistance
35. A controlled trial of immunotherapy in insect hypersensitivity
36. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock
37. Anaphylactoid reaction to an initial dose of sodium cephalothin
38. Multiple antibiotic sensitivity in a pediatric population
39. Penicillin reactions: Their nature, growing importance, recognition, management and prevention
40. The multiple drug allergy syndrome: A matched-control retrospective study in patients allergic to penicillin
41. Evidence for familial aggregation of immunologic drug reactions
42. Ciprofloxacin desensitization in a patient with cystic fibrosis
43. Successful clarithromycin desensitization in a macrolide-sensitive patient
44. The incidence of antimicrobial allergies in hospitalized patients: Implications regarding prescribing patterns and emerging bacterial resistance
45. Desensitization to vancomycin
46. Antigenicity and cross-reactivity of penicillins and cephalosporins
47. Immunologic mechanisms of penicillin allergy - A haptenic model system for the study of allergic diseases in man
48. Studies on the mechanism of the formation of the penicillin antigen. III: The N-(D-α-benzyl-penicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G
49. Minor haptenic determinant-specific reagins of penicillin hypersensitivity in man
50. Prediction of penicillin allergy by immunological tests
51. Desensitization in the management of vancomycin hypersensitivity
52. Booster responses in the study of allergic reactions to β-lactam antibiotics
53. Skin testing with penicilloate and penilloate prepared by an improved method: Amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents
54. Preparation and analysis of penicilloic acid and penilloic acid using high resolution nuclear magnetic resonance
55. Routine elective penicillin allergy skin testing in children and adolescents: Study of sensitization
56. Anaphylactoid reactions to ciprofloxacin in cystic fibrosis patients
57. HLA antigens in Stevens-Johnson syndrome with ocular involvement
58. Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome
59. Allergic reactions to antimicrobial drugs in patients with a history of prior drug allergy
60. Vancomycin-resistant enterococci
61. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin
62. Anaphylaxis to benzathine penicillin G
63. Emergent levofloxacin desentization in acute myelogenous leukemia
64. Drug disposition and drug hypersensitivity
65. Practical aspects of diagnosis and treatment of patients who are hypersensitive to drugs
66. The preparation and some properties of penicillenic acid derivatives relevant to penicillin hypersensitivity
67. Penicillin resensitization among hospitalized patients
68. Skin rash with infectious mononucleosis and ampicillin
69. Immunologic cross-reactivity between penicillins and cephalosporins: A review
70. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: Reliability of examination assessed by skin testing and oral challenge
71. Idiosyncratic drug reactions: Metabolic bioactivation as a pathogenic mechanism
72. Anaphylactoid reactions to glycopeptide antibiotics
73. Allergy to β-lactam antibiotics in children
74. Under-reporting of antibiotic anaphylaxis may put patients at risk
75. Risk factors for the spread of antibiotic-resistant bacteria
76. A liquid chromatographic study of stability of the minor chromatographic determinants of penicillin allergy: A stable determinant mixture skin test preparation
77. Immediate allergic reactions to cephalosporins: Cross reactivity and selective responses
78. Cephalothin reactions after penicillin sensitization
79. Genetic susceptibility to toxic epidermal necrolysis
80. Immediate hypersensitivity reactions to β-lactam antibiotics
81. Anaphylaxis to cephalothin in a patient allergic to penicillin
82. An epidemiologic study of insect allergy in children. II: The effect of accidental stings in allergic children
83. Anaphylaxis to penicillin in a frozen dinner
84. Mechanisms of drug reactions: The metabolic track
85. Clinical experience using only PrePen and penicillin G to detect penicillin allergy in hospitalized patients
86. Immunological cross-reactivity of cephalothin and its related compounds with benzylpenicillin (penicillin G)
87. Studies on the epidemiology of adverse drug reactions. II: An evaluation of penicillin allergy
88. Penicillin allergy
89. Results of the National Institute of Allergy and Infectious Diseases collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults
90. Clinical approach to penicillin allergic patients: A survey
91. Penicillin allergy: Prevalence of vague history in skin test-positive patients
92. Penicillin resensitization in patients with a history of penicillin allergy
93. Penicillin allergy: Clinical experience with a battery of skin-test reagents
94. Successful vancomycin desensitization in a patient with end-stage renal disease and anaphylactic shock to vancomycin
95. Two surgical deaths associated with cephalothin
96. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin
97. Antigen-specific desensitization of patients allergic to penicillin
98. Studies of the multiple drug allergy syndrome
99. Drug allergy
100. Skin testing to detect penicillin allergy
101. Desensitization of patients allergic to penicillin using orally administered β-lactam antibiotics
102. Frequency of systematic reactions to penicillin skin tests
103. Anaphylactoid reactions to quinolones
104. Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization
105. Penicillin allergy and desensitization in serious infections during pregnancy
106. Anaphylactic reaction to penicillin (or penicillin-like substance) in a soft drink
107. Allergic reaction to penicillin present in milk
108. Allergy to β-lactams: A survey of current practices
109. Fatal delayed anaphylactic shock after penicillin
110. Vancomycin hypersensitivity: Synergism with narcotics and "desensitization" by a rapid continuous intravenous protocol
111. HLA-DR antigens and toxic reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis